| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Reversed phase POSITIVE ION MODE | F11 | Sample source:Brain | Genotype:3xTg | Treatment:Control | ng lipid/mg brain |
| Reversed phase POSITIVE ION MODE | F12 | Sample source:Brain | Genotype:3xTg | Treatment:Control | ng lipid/mg brain |
| Reversed phase POSITIVE ION MODE | F13 | Sample source:Brain | Genotype:3xTg | Treatment:Control | ng lipid/mg brain |
| Reversed phase POSITIVE ION MODE | F14 | Sample source:Brain | Genotype:3xTg | Treatment:Control | ng lipid/mg brain |
| Reversed phase POSITIVE ION MODE | F15 | Sample source:Brain | Genotype:3xTg | Treatment:Control | ng lipid/mg brain |
| Reversed phase POSITIVE ION MODE | M11 | Sample source:Brain | Genotype:3xTg | Treatment:Control | ng lipid/mg brain |
| Reversed phase POSITIVE ION MODE | M12 | Sample source:Brain | Genotype:3xTg | Treatment:Control | ng lipid/mg brain |
| Reversed phase POSITIVE ION MODE | M13 | Sample source:Brain | Genotype:3xTg | Treatment:Control | ng lipid/mg brain |
| Reversed phase POSITIVE ION MODE | M14 | Sample source:Brain | Genotype:3xTg | Treatment:Control | ng lipid/mg brain |
| Reversed phase POSITIVE ION MODE | M15 | Sample source:Brain | Genotype:3xTg | Treatment:Control | ng lipid/mg brain |
| Reversed phase POSITIVE ION MODE | F16 | Sample source:Brain | Genotype:3xTg | Treatment:Protein restriction | ng lipid/mg brain |
| Reversed phase POSITIVE ION MODE | F17 | Sample source:Brain | Genotype:3xTg | Treatment:Protein restriction | ng lipid/mg brain |
| Reversed phase POSITIVE ION MODE | F18 | Sample source:Brain | Genotype:3xTg | Treatment:Protein restriction | ng lipid/mg brain |
| Reversed phase POSITIVE ION MODE | F19 | Sample source:Brain | Genotype:3xTg | Treatment:Protein restriction | ng lipid/mg brain |
| Reversed phase POSITIVE ION MODE | F20 | Sample source:Brain | Genotype:3xTg | Treatment:Protein restriction | ng lipid/mg brain |
| Reversed phase POSITIVE ION MODE | M16 | Sample source:Brain | Genotype:3xTg | Treatment:Protein restriction | ng lipid/mg brain |
| Reversed phase POSITIVE ION MODE | M17 | Sample source:Brain | Genotype:3xTg | Treatment:Protein restriction | ng lipid/mg brain |
| Reversed phase POSITIVE ION MODE | M18 | Sample source:Brain | Genotype:3xTg | Treatment:Protein restriction | ng lipid/mg brain |
| Reversed phase POSITIVE ION MODE | M19 | Sample source:Brain | Genotype:3xTg | Treatment:Protein restriction | ng lipid/mg brain |
| Reversed phase POSITIVE ION MODE | M20 | Sample source:Brain | Genotype:3xTg | Treatment:Protein restriction | ng lipid/mg brain |
| Reversed phase POSITIVE ION MODE | F1 | Sample source:Brain | Genotype:Non-transgenic | Treatment:Control | ng lipid/mg brain |
| Reversed phase POSITIVE ION MODE | F2 | Sample source:Brain | Genotype:Non-transgenic | Treatment:Control | ng lipid/mg brain |
| Reversed phase POSITIVE ION MODE | F3 | Sample source:Brain | Genotype:Non-transgenic | Treatment:Control | ng lipid/mg brain |
| Reversed phase POSITIVE ION MODE | F4 | Sample source:Brain | Genotype:Non-transgenic | Treatment:Control | ng lipid/mg brain |
| Reversed phase POSITIVE ION MODE | F5 | Sample source:Brain | Genotype:Non-transgenic | Treatment:Control | ng lipid/mg brain |
| Reversed phase POSITIVE ION MODE | M1 | Sample source:Brain | Genotype:Non-transgenic | Treatment:Control | ng lipid/mg brain |
| Reversed phase POSITIVE ION MODE | M2 | Sample source:Brain | Genotype:Non-transgenic | Treatment:Control | ng lipid/mg brain |
| Reversed phase POSITIVE ION MODE | M3 | Sample source:Brain | Genotype:Non-transgenic | Treatment:Control | ng lipid/mg brain |
| Reversed phase POSITIVE ION MODE | M4 | Sample source:Brain | Genotype:Non-transgenic | Treatment:Control | ng lipid/mg brain |
| Reversed phase POSITIVE ION MODE | M5 | Sample source:Brain | Genotype:Non-transgenic | Treatment:Control | ng lipid/mg brain |
| Reversed phase POSITIVE ION MODE | F10 | Sample source:Brain | Genotype:Non-transgenic | Treatment:Protein restriction | ng lipid/mg brain |
| Reversed phase POSITIVE ION MODE | F6 | Sample source:Brain | Genotype:Non-transgenic | Treatment:Protein restriction | ng lipid/mg brain |
| Reversed phase POSITIVE ION MODE | F7 | Sample source:Brain | Genotype:Non-transgenic | Treatment:Protein restriction | ng lipid/mg brain |
| Reversed phase POSITIVE ION MODE | F8 | Sample source:Brain | Genotype:Non-transgenic | Treatment:Protein restriction | ng lipid/mg brain |
| Reversed phase POSITIVE ION MODE | F9 | Sample source:Brain | Genotype:Non-transgenic | Treatment:Protein restriction | ng lipid/mg brain |
| Reversed phase POSITIVE ION MODE | M10 | Sample source:Brain | Genotype:Non-transgenic | Treatment:Protein restriction | ng lipid/mg brain |
| Reversed phase POSITIVE ION MODE | M6 | Sample source:Brain | Genotype:Non-transgenic | Treatment:Protein restriction | ng lipid/mg brain |
| Reversed phase POSITIVE ION MODE | M7 | Sample source:Brain | Genotype:Non-transgenic | Treatment:Protein restriction | ng lipid/mg brain |
| Reversed phase POSITIVE ION MODE | M8 | Sample source:Brain | Genotype:Non-transgenic | Treatment:Protein restriction | ng lipid/mg brain |
| Reversed phase POSITIVE ION MODE | M9 | Sample source:Brain | Genotype:Non-transgenic | Treatment:Protein restriction | ng lipid/mg brain |
Return to study ST003215 main page
Download data matrix(Protein restriction slows the development and progression of Alzheimer's disease in mice Reversed phase POSITIVE ION MODE)
- Metabolomics Workbench
|